Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1886 1
1953 1
1954 3
1958 1
1961 1
1966 1
1973 1
1978 1
1980 1
2000 2
2001 1
2003 1
2004 7
2005 11
2006 13
2007 8
2008 5
2009 6
2016 1
2017 1
2022 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 14962700

64 results
Results by year
Filters applied: . Clear all
Page 1
A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
Vasilev K, Reshedko G, Orasan R, Sanchez M, Teras J, Babinchak T, Dukart G, Cooper A, Dartois N, Gandjini H, Orrico R, Ellis-Grosse E; 309 Study Group. Vasilev K, et al. J Antimicrob Chemother. 2008 Sep;62 Suppl 1:i29-40. doi: 10.1093/jac/dkn249. J Antimicrob Chemother. 2008. PMID: 18684704 Clinical Trial.
64 results